Behcet's disease: Treatment of mucocutaneous lesions

Alpsoy E.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.23, sa.4, ss.532-539, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 23 Sayı: 4
  • Basım Tarihi: 2005
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.532-539
  • Anahtar Kelimeler: Behcet's disease, treatment, review, oral ulcer, genital ulcer, cutaneous lesions, RECURRENT APHTHOUS STOMATITIS, DOUBLE-BLIND TRIAL, TOPICAL ALPHA-INTERFERON, SUCRALFATE SUSPENSION, CLINICAL-TRIAL, ORAL ULCERS, 5-PERCENT AMLEXANOX, ULCERATION, LEVAMISOLE, COLCHICINE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Oral and genital ulcers, and cutaneous vasculitic lesions are considered hallmarks of the disease, and often precede other manifestations. Mucocutaneous lesions figure prominently in the presentation and diagnosis. Therefore, their recognition may permit earlier diagnosis and treatment, with beneficial results for prognosis. This review overviews the current state of knowledge regarding the therapeutic approaches including local and systemic agents for the treatment of mucocutaneous lesions of BD.